Furthermore, among all specimens of the small group (30 breast tumor specimens) examined, TSP50+/MMP9+ tumors were also associated with a higher metastasis rate and poor patient survival (Figure 7f). This evidence concerns the gene PRSS50 and breast neoplasm.